Bispecific Antibodies Overcome the Opsonin-Receptor Mismatch of Cystic Fibrosis in Vitro: Restoration of Neutrophil-Mediated Phagocytosis and Killing of Pseudomonas aeruginosa

Journal of Immunology

Volumn 158, Issue 7, 1997, Pages 3474-3482

  McCormick, Laura L ^a   Karulin, Alexey Y ^a   Schreiber, John R ^a   Greenspan, Neil S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; CD18 ANTIGEN; COMPLEMENT; IMMUNOGLOBULIN RECEPTOR; OPSONIN; OPSONIN RECEPTOR;

ANTIBODY SPECIFICITY; ARTICLE; CELL CULTURE; CELL SEPARATION; CHEMISTRY; CYSTIC FIBROSIS; FLOW CYTOMETRY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NEUTROPHIL; PHAGOCYTOSIS; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA;

ANTIBODIES, BISPECIFIC; ANTIBODY SPECIFICITY; ANTIGENS, CD18; CELL SEPARATION; CELLS, CULTURED; COMPLEMENT SYSTEM PROTEINS; CYSTIC FIBROSIS; FLOW CYTOMETRY; HUMANS; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; PROTEIN BINDING; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RECEPTORS, IMMUNOLOGIC;

EID: 0031114044     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Riordan, J. R., J. M. Rommens, B. W. Kerem, N. Alon, R. Rozmahel, Z. Grzelczak, J. Zielenski, S. Lok, N. Plavsic, J. L. Chou, M. L. Drumm, M. C. Iannuzzi, F. S. Collins, and L. C. Tsui. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066.
2. Klinger, K. W. 1985. Genetics of cystic fibrosis. Semin. Respir. Med. 6:243.
3. Anderson, M. P., R. J. Gregory, S. Thompson, D. W. Souza, S. Paul, R. C. Mulligan, A. E. Smith, and M. J. Welch. 1991. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 253:202.
4. Bear, C., C. Li, N. Kartner, R. J. Bridges, T. J. Jensen, M. Ramjeesingh, and J. R. Riordan. 1992. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68:809.
5. Pedersen, S. S. 1992. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 100 (Suppl. 28):1.
6. Wood, R. E., T. F. Boat, and C. F. Doershuk. 1976. State of the art: cystic fibrosis. Am. Rev. Respir. Dis. 113:833.
7. Konstan, M. W., and M. Berger. 1993. Infection and inflammation of the lung in cystic fibrosis. In Cystic Fibrosis, Lung Biology in Health and Disease. P. B. Davis, ed. Marcel Dekker, New York, p. 219.
8. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229.
9. Joiner, K. A., E. J. Brown, and M. M. Frank. 1984. Complement and bacteria: chemistry and biology in host defense. Annu. Rev. Immunol. 2:461.
10. Rosen, H., and S. K. A. Law. 1989. The leukocyte cell surface receptor(s) for the iC3b product of complement. Curr. Top. Microbiol. Immunol. 153:99.
11. Ross, G. D., and J. D. Lambriss. 1982. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes. J. Exp. Med. 155:96.
12. Wright, S. D., J. I. Weitz, A. J. Huang, S. M. Levin, S. C. Silverstein, and J. D. Loike. 1988. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc. Natl. Acad. Sci. USA 85:7734.
13. Wright, S. D., and M. T. C. Jong. 1986. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 164:1876.
14. Wright, S. D., S. M. Levin, M. T. C. Jong, Z. Chad, and L. G. Kabbash. 1989. CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide. J. Exp. Med. 164:175.
15. Ross, G. D., J. A. Cain, B. L. Myones, S. L. Newman, and P. J. Lachmann. 1987. Specificity of membrane complement receptor type three (CR3) for β-glucans. Complement 4:61.
16. Relman, D., E. Tuomanen, S. Falkow, D. T. Golenbock, K. Saukkonen, and S. D. Wright. 1990. Recognition of a bacterial adhesjn by an integrin: macrophage CR3 (CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375.
17. Russell, D. G., and S. D. Wright. 1988. Complement receptor type 3 (CR3) binds to an Arg-Gly-Asp-containing region of the major surface glycoprotein, gp63, of Leishmania promastigotes. J. Exp. Med. 168:279.
18. 2, Mac-1). J. Immunol. 151:3324.
19. Berger, M., R. U. Sorensen, M. F. Tosi, D. G. Dearborn, and G. Doring. 1989. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J. Clin. Invest. 84:1302.
20. Tosi, M. F., H. Zakem, and M. Berger. 1990. Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J. Clin. Invest. 86:300.
21. Tosi, M., and M. Berger. 1988. Functional differences between the 40kDa and 50 to 60 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and anti-receptor antibodies. J. Immunol. 141:2097.
22. Fick, R. B., Jr., G. P. Naegel, S. U. Squier, R. E. Wood, J. B. C. Gee, and H. Y. Reynolds. 1984. Proteins of the cystic fibrosis respiratory tract: fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis. J. Clin. Invest. 74:236.
23. Staerz, U. D., O. Kanagawa, and M. J. Bevan. 1985. Hybrid antibodies can target sites for attack by T cells. Nature 314:628.
24. Taylor, R. P., W. M. Sutherland, C. J. Reist, D. J. Webb, E. L. Wright, and R. H. Labuguen. 1991. Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment. Proc. Natl. Acad. Sci. USA 88:3305.
25. Taylor, R. P., C. J. Reist, W. M. Sutherland, A. Otto, R. H. Labuguen, and E. L. Wright. 1992. In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor. J. Immunol. 148:2462.
26. Fanger, M. W., P. M. Morganelli, and P. M. Guyre. 1992. Bispecific antibodies. Crit. Rev. Immunol. 12:101.
27. Bertozzi, C. R., and M. D. Bednarski. 1992. A receptor-mediated immune response using synthetic glycoconjugates. J. Am. Cfiem. Soc. 114:5543.
28. Klebanoff, S. J., P. G. Beatty, R. D. Schreiber, H. D. Ochs, and A. M. Waltersdorph. 1985. Effect of antibodies to complement receptors on phagocytosis by polymorphonuclear leukocytes: use of iodination as a convenient measure of phagocytosis. J. Immunol. 134:1153.
29. Schreiber, J. R., L. J. N. Cooper, S. Diehn, P. A. Dahlhauser, M. F. Tosi, D. D. Glass, M. Patawaran, and N. S. Greenspan. 1993. Variable region-identical monoclonal antibodies of different IgG subclass directed to Pseudomonas aeruginosa lipopolysaccharide O-specific side chain function differently. J. Infect. Dis. 167:221.
30. Henwick, W., S. V. Hetherington, and M. K. Hosteller. 1992. Specificity of three anti-complement factor 3 monoclonal antibodies. J. Immunol. Methods 153:173.
31. Cantinieaux, B., C. Hariga, P. Courtoy, J. Hupin, and P. Fondu. 1989. Staphylococcus aureus phagocytosis: a new cytofluorometric method using FITC and paraformaldehyde. J. Immunol. Methods 121:203.
32. Ishikawa, E., M. Imagawa, S. Hashida, S. Yoshitake, Y. Hamaguchi, and T. Ueno. 1983. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. J. Immunoassay 4:209.
33. Zhou, M., and E. J. Brown. 1993. Leukocyte response integrin and integrin-associated protein act as a signal transduction unit in generation of a phagocyte respiratory burst. J. Exp. Med. 178:1165.
34. Drevets, D. A., and P. A. Campbell. 1991. Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect. Immun. 59:2645.
35. Edwards, M. S., C. J. Baker, and D. L. Kasper. 1979. Opsonic specificity of human antibody to the type III polysaccharide of group B streptococcus. J. Infect. Dis. 140:1004.
36. Berger, M., T. M. Norvell, M. F. Tosi, S. N. Emancipator, M. W. Konstan, and J. R. Schreiber. 1994. Tissue-Specific Fcγ and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr. Res. 35:68.
37. Krauss, J. C., H. Poo, W. Xue, L., Mayo-Bond, R. F. Todd III, and H. R. Petty. 1994. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fcγ receptor IIIB and the complement receptor type 3. J. Immunol. 153:1769.
38. Edberg, J. C., and R. P. Kimberly. 1994. Modulation of Fcγ and complement receptor function by the glycosyl-phosphatidylinositol-anchored form of FcγRIII. J. Immunol. 152:5826.
39. Berman, M. E., and W. A. Muller. 1995. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J. Immunol. 154:299.
40. Fallman, M., R. Andersson, and T. Andersson. 1993. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles. J. Immunol. 151:330.
41. Mosser, D. M. 1994. Receptors on phagocytic cells involved in microbial recognition. Immunol. Ser. 60:99.
42. Mulo, S., V. Vetvicka, and G. D. Ross. 1993. CR3 (CD11b/CD18) expressed by cytotoxic T cells and natural killer cells is upregulated in a manner similar to neutrophil CR3 following stimulation with various activating agents. J. Clin. Immunol. 13:175.
43. Hann, S., and D. S. Holsclaw. 1978. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum. Infect. Immun. 14:114.
44. Hatano, K., J. B. Goldberg, and G. B. Pier. 1995. Biologic activities of antibodies to the neutral-polysaccharide component of the Pseudomonas aeruginosa lipopolysaccharide are blocked by O side chains and mucoid exopolysaccharide (alginate). Infect. Immun. 63:21.
45. Boxerbaum, B., M. Kagumba, and L. W. Matthews. 1973. Selective inhibition of phagocytic activity of rabbit alveolar macrophages by cystic fibrosis serum. Am. Rev. Respir. Dis. 108:777.
46. Shalaby, M. R., H. M. Shepard, L. Presta, M. L. Rodrigues, P. C. L. Beverley, M. Feldmann, and P. Carter. 1992. Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. J. Exp. Med. 175:2217.
47. Fuchs, H. L., D. S. Borowitz, D. H. Christiansen, E. M. Morris, M. L. Nash, B. W. Ramsey, B. J. Rosenstein, A. L. Smith, and M. E. Wohl. 1994. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary functions in patients with cystic fibrosis. N. Engl. J. Med. 331:637.
48. Vasconcellos, C. A., P. G. Allen, M. E. Wohl, J. M. Drazen, P. A. Jannel, and T. P. Stossel. 1994. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263:969.